Cardiometabolic Health Congress (CMHC)
Avatar

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

By Cardiometabolic Health Congress (CMHC) FEATURING Lance Sloan
By Cardiometabolic Health Congress (CMHC) FEATURING Lance Sloan
7,857 views
June 17, 2019
2 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
06:38
Allan Jaffe

What Does Elevated Troponin Mean in COVID-19?

64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
11:37
ACC 2022 Conference Coverage

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

Feat. P. Heidenreich
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
31:46
ACC 2024 Insights

ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With …

Feat. M. Costanzo
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

20:24
Diana Isaacs

Tirzepatide for Type 2 Diabetes

21:19
Patricia Kao

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

52:36
University of Colorado Department of Medicine

The 2024 Collins Distinguished Lectureship - Kidney Stones: Canary i…

Feat. E. Worcester
14:19
UChicago Medicine

S-QUAD Therapy and Beyond: HFpEF in 2024

Feat. M. Belkin
26:49
Diana Isaacs

Tirzepatide Updates

06:51
Susan Brian

Discussing SURMOUNT Trials: Tirzepatide for Weightloss

49:44
PKD Foundation

Dialysis 101: Understanding Chronic Kidney Disease and Dialysis

Feat. B. Cowley
06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

13:33
Dr. Sharmila Ghimire

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesi…

Feat. D. Ghimire